Company Overview

Update
Founded:
2001
Founders:
Michael Carroll
Headquarters:
Boston, MA
Funding:
$5.5M
Categories:
Biotechnology
Description:
DecImmune Therapeutics is a Boston-based biotech company developing drugs for inflammation and autoimmunity.

Detailed Description

Update

DecImmune Therapeutics, Inc., a biotechnology company, manufactures drugs for inflammation and autoimmunity. The company was incorporated in 2001 and is based in Boston, Massachusetts.

Past Team (1)

Update

Board Members and Advisors (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    800 Huntington Avenue

    Boston, MA 02115

    USA